Oarsman Capital’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,317
Closed -$29K 776
2024
Q4
$29K Buy
+1,317
New +$24K 0.01% 542
2019
Q2
Sell
-10,517
Closed -$165K 181
2019
Q1
$165K Sell
10,517
-780
-7% -$13.8K 0.08% 169
2018
Q4
$174K Sell
11,297
-550
-5% -$11.3K 0.09% 166
2018
Q3
$255K Buy
11,847
+1,090
+10% +$25.3K 0.1% 160
2018
Q2
$262K Sell
10,757
-1,400
-12% -$28.6K 0.12% 151
2018
Q1
$208K Sell
12,157
-1,892
-13% -$36.9K 0.09% 170
2017
Q4
$266K Sell
14,049
-3,715
-21% -$55.9K 0.11% 160
2017
Q3
$313K Sell
17,764
-43,128
-71% -$970K 0.13% 147
2017
Q2
$2.02M Buy
60,892
+6,432
+12% +$199K 0.92% 36
2017
Q1
$1.75M Buy
54,460
+15,588
+40% +$532K 0.81% 39
2016
Q4
$1.41M Sell
38,872
-967
-2% -$38.6K 0.91% 36
2016
Q3
$1.83M Buy
39,839
+1,553
+4% +$81K 0.93% 35
2016
Q2
$1.92M Buy
38,286
+5,851
+18% +$311K 1% 32
2016
Q1
$1.74M Buy
32,435
+855
+3% +$50.2K 0.92% 39
2015
Q4
$2.07M Buy
31,580
+6,026
+24% +$372K 1.16% 23
2015
Q3
$1.44M Sell
25,554
-360
-1% -$23.3K 0.85% 39
2015
Q2
$1.53M Buy
25,914
+335
+1% +$20.7K 1.04% 28
2015
Q1
$1.59M Buy
25,579
+310
+1% +$18K 1.1% 28
2014
Q4
$1.45M Sell
25,269
-10
-0% -$557 1.05% 30
2014
Q3
$1.36M Buy
25,279
+145
+0.6% +$7.68K 1% 31
2014
Q2
$1.32M Buy
25,134
+505
+2% +$25.8K 0.96% 31
2014
Q1
$1.3M Sell
24,629
-355
-1% -$16.4K 1% 29
2013
Q4
$1M Sell
24,984
-5,895
-19% -$232K 0.8% 43
2013
Q3
$1.17M Buy
30,879
+1,965
+7% +$76.7K 1.02% 30
2013
Q2
$1.13M Buy
+28,914
New +$1.13M 1.07% 31

Other funds holding TEVA